Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

The National Evaluation System for health Technology (NEST), an initiative of the Medical Device Innovation Consortium (MDIC), is pleased to welcome Hologic, a leading global medical device and diagnostic company, to its Governance Committee. This appointment reflects Hologic’s commitment to…

Read MoreHologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation
Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

Revvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows

–Revvity, Inc. (NYSE: RVTY), today announced the launch of three Mimix™ reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays designed to detect somatic mutations in genomic DNA (gDNA) from…

Read MoreRevvity Introduces New IVD Reference Standards for Monitoring Oncology Diagnostic Testing Workflows
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity

Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity

A. New proteoElute nanoflow nLC system features ceramic valves, proteoTrap trapping columns, and TwinScape-enabled predictive maintenance technology B. Introducing new generation of PepSep Advanced nLC columns to further improve chromatographic resolution, sensitivity and proteomics identifications At the 73rd Conference on Mass Spectrometry and…

Read MoreBruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
Clairity Becomes First FDA-Authorized AI for Breast Cancer Prediction

Clairity Becomes First FDA-Authorized AI for Breast Cancer Prediction

Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA)De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With…

Read MoreClairity Becomes First FDA-Authorized AI for Breast Cancer Prediction
Growve Secures Majority Equity Investment led by Palm Beach Capital and Debt Financing from TCW and NMP Capital

Growve Secures Majority Equity Investment led by Palm Beach Capital and Debt Financing from TCW and NMP Capital

Growve, a leader in the health and wellness industry, announced today that it has secured a majority equity investment led by Palm Beach Capital (PBC), with participation from G-Bar Ventures and NMP Capital. As part of the transaction, Growve also closed on new debt…

Read MoreGrowve Secures Majority Equity Investment led by Palm Beach Capital and Debt Financing from TCW and NMP Capital